We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEX
2651
DELISTED
Emerald Holding
EEX
$2.44K ﹤0.01%
507
+458
+935% +$2.1K
INBX icon
2652
Inhibrx
INBX
$1.37B
$2.43K ﹤0.01%
158
+152
+2,533% +$2.31K
PHLT
2653
DELISTED
Performant Healthcare Inc
PHLT
$2.43K ﹤0.01%
804
+684
+570% +$2.35K
RDZN icon
2654
Roadzen
RDZN
$108M
$2.42K ﹤0.01%
1,111
+1,065
+2,315% +$1.31K
CAKE icon
2655
Cheesecake Factory
CAKE
$5.53B
$2.42K ﹤0.01%
51
+1
+2% +$46
ACRV icon
2656
Acrivon Therapeutics
ACRV
$74.5M
$2.41K ﹤0.01%
401
+364
+984% +$2.65K
TNDM icon
2657
Tandem Diabetes Care
TNDM
$1.59B
$2.41K ﹤0.01%
67
DIBS icon
2658
1stdibs.com
DIBS
$153M
$2.4K ﹤0.01%
679
+610
+884% +$2.47K
ATXS
2659
DELISTED
Astria Therapeutics
ATXS
$2.4K ﹤0.01%
268
+208
+347% +$2.21K
COGT icon
2660
Cogent Biosciences
COGT
$7.1B
$2.38K ﹤0.01%
305
+198
+185% +$1.97K
RIGL icon
2661
Rigel Pharmaceuticals
RIGL
$778M
$2.37K ﹤0.01%
141
+115
+442% +$2.21K
YOU icon
2662
Clear Secure
YOU
$5.27B
$2.37K ﹤0.01%
89
CPRX
2663
DELISTED
Catalyst Pharmaceutical
CPRX
$2.36K ﹤0.01%
113
DOCN icon
2664
DigitalOcean
DOCN
$15.3B
$2.35K ﹤0.01%
69
+1
+1% +$39
CAPR icon
2665
Capricor Therapeutics
CAPR
$223M
$2.33K ﹤0.01%
169
+135
+397% +$2.37K
DHIL
2666
DELISTED
Diamond Hill
DHIL
$2.33K ﹤0.01%
15
+11
+275% +$1.76K
JJSF icon
2667
J&J Snack Foods
JJSF
$1.68B
$2.33K ﹤0.01%
15
LFMD icon
2668
LifeMD
LFMD
$174M
$2.33K ﹤0.01%
470
+406
+634% +$2.13K
ARDT
2669
Ardent Health
ARDT
$1.59B
$2.32K ﹤0.01%
136
+114
+518% +$1.98K
CLSK icon
2670
CleanSpark
CLSK
$2.97B
$2.32K ﹤0.01%
252
+27
+12% +$326
MODV
2671
DELISTED
ModivCare
MODV
$2.32K ﹤0.01%
196
+172
+717% +$2.72K
CYRX icon
2672
CryoPort
CYRX
$747M
$2.32K ﹤0.01%
298
+236
+381% +$1.76K
PTGX icon
2673
Protagonist Therapeutics
PTGX
$9.71B
$2.32K ﹤0.01%
60
EVCM icon
2674
EverCommerce
EVCM
$1.81B
$2.31K ﹤0.01%
210
+176
+518% +$1.97K
ACLS icon
2675
Axcelis
ACLS
$4.1B
$2.31K ﹤0.01%
33

Similar funds

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.